Tenon Medical, Inc. (TNON) is up 176.5% today. Here is some analysis on what might have caused this price movement.
Analysis: The rally appears tied to a mix of improving business momentum and technical trading factors. Tenon recently posted sharply higher second-quarter revenue and gross profit, highlighted a new FDA clearance, and said July reached record monthly case volume. This could also be because the stock only recently completed a 1-for-35 reverse split, which can make moves more volatile when momentum buyers rush in.
Details:
Sources:
SEC, FDA, Nasdaq, ACCESS Newswire
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$TNON Hedge Fund Activity
We have seen 8 institutional investors add shares of $TNON stock to their portfolio, and 10 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ARMISTICE CAPITAL, LLC added 172,105 shares (+inf%) to their portfolio in Q2 2026, for an estimated $1,965,525
- DRW SECURITIES, LLC removed 102,521 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $2,603,623
- XTX TOPCO LTD removed 18,856 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $478,866
- VIRTU FINANCIAL LLC removed 15,269 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $387,771
- WARBERG ASSET MANAGEMENT LLC added 12,297 shares (+inf%) to their portfolio in Q2 2026, for an estimated $140,437
- TWO SIGMA SECURITIES, LLC removed 11,604 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $294,695
- CITIGROUP INC removed 8,127 shares (-82.4%) from their portfolio in Q2 2026, for an estimated $2,651
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.